WCN26-8581 PREDICTION OF RESPONSE TO VASOCONSTRICTORS IN HEPATORENAL SYNDROME WITH FRACTIONAL EXCRETION OF URINARY SODIUM AND URINARY SEDIMENT MICROSCOPY

Read full text Summarise with VIRAT
Authors: Juan Carlos Q. Velez, Cruz Velasco‐Gonzalez
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Hepatorenal syndrome (HRS) is a serious form of acute kidney injury (AKI) in cirrhosis. Vasoconstrictor (VC) therapy is the cornerstone of its pharmacological treatment. However, here are no optimal biomarkers to predict therapeutic response (TR) to VC therapy in HRS-AKI. We hypothesized that utilizing fractional excretion of urinary sodium (FENa) (as functional biomarker) and/or evidence of acute tubular insult (ATI) by urinary sediment microscopy (uSEDI) (as injury biomarker) may allow predicting TR to VC in HRS-AKI.

Fields of Study & Subjects

Liver Disease and Transplantation Acute Kidney Injury Research Electrolyte and hormonal disorders

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105706–105706
Publication date
25 March 2026
Language
EN